Description

Lenercept CAS NO 156679-34-4 is a recombinant fusion protein designed to modulate specific immune signaling pathways. This compound is of significant interest in advanced pharmaceutical research and development due to its targeted biological activity. It is primarily utilized by biotechnology and pharmaceutical companies engaged in the discovery and production of novel therapeutic agents for inflammatory and autoimmune conditions.

Application

• Biopharmaceutical Research: A key reagent in the study of cytokine signaling and immune response modulation.
• Therapeutic Development: Serves as a critical reference standard or active component in the formulation of investigational biologic drugs.
• Cell Culture & Assay Systems: Used in in vitro studies to investigate receptor-ligand interactions and cellular pathways.
• Preclinical Studies: Employed in animal models to evaluate efficacy and pharmacokinetics for potential inflammatory disease treatments.
• Process Development: Acts as a standard in downstream purification and analytical method development for protein-based therapeutics.

Basic Information

Product Name	Lenercept
CAS No.	156679-34-4
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	TNFR-IgG Fusion Protein; p55-IgG; Ro 45-2081; TNF Receptor (55 kDa) Fc Fusion Protein; Tumor Necrosis Factor Receptor Fusion Protein; Lenercept (TNFR55-IgG1)
EINECS	Contact for details

Quality Control

Our Lenercept is produced and tested under stringent quality management systems. Each batch undergoes comprehensive analytical characterization to ensure identity, purity, potency, and consistency. Certificates of Analysis (COA) detailing specifications such as purity by HPLC, endotoxin levels, and biological activity are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below. This product is hygroscopic (moisture-sensitive). For long-term storage, keep desiccated. Avoid repeated freeze-thaw cycles.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder
Identification (HPLC/MS)	Conforms
Purity (SDS-PAGE)	≥ 95%
Assay (HPLC)	≥ 98.0%
Endotoxin	< 1.0 EU/mg
Biological Activity	Determined by cell-based assay
Moisture Content (KF)	< 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.